Frontiers
US$ 23.37
glp-1 drugs and anxiety The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Association between GLP-1 receptor agonist
Description
X., et al., Body Weight Management in Overweight and Obese Breast Cancer Survivors, Cochrane Database of Systematic Reviews 12 (2020): Cd012110
00014-3/asset/c6c68f71-1303-4dbd-81fc-c7e57d64925d/main.assets/gr2_lrg.jpg)
doi: 10.1111/1753-0407.12198 172 RosenstockJSorliCHTrautmannMEMoralesCWendischUDaileyGet al
I think knowing that going in, while understanding the current side effects of GLP-1s, is your best tool for making a decision about the medication. Published August 2025
Diabetes 2023, 73, 3850
A., Petrov, A
For some people who are doing well and tolerating the medication, a lower maintenance dose may be part of the plan
